Prevalence of peripheral neuropathy among patients diagnosed with type 2 Diabetes Mellitus and to determine the correlation between level of vit. B12 and peripheral neuropathy
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2024
Project Lead
Ms. Kripa Susan
Authors
Ms. Kripa Susan (IV B.Sc.) & Mrs. Neethu Paul, Asso. Prof.
Project Status
completed
Project Type
Student